Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

NovaBridge Biosciences (NBP) Leases (2019 - 2025)

NovaBridge Biosciences (NBP) has 7 years of Leases data on record, last reported at $2.8 million in Q4 2025.

  • On a quarterly basis, Leases fell 21.91% to $2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 million, a 21.91% decrease, with the full-year FY2025 number at $2.8 million, down 21.91% from a year prior.
  • Leases reached $2.8 million in Q4 2025 per NBP's latest filing, down from $3.0 million in the prior quarter.
  • Over the last five years, Leases for NBP hit a ceiling of $17.6 billion in Q4 2021 and a floor of $2.8 million in Q4 2025.
  • A 5-year average of $1.4 billion and a median of $3.7 million in 2024 define the central range for Leases.
  • Peak YoY movement for Leases: surged 779415.91% in 2021, then tumbled 99.95% in 2022.
  • Tracing NBP's Leases over 5 years: stood at $17.6 billion in 2021, then crashed by 99.95% to $8.9 million in 2022, then fell by 27.39% to $6.4 million in 2023, then tumbled by 44.18% to $3.6 million in 2024, then dropped by 21.91% to $2.8 million in 2025.
  • Business Quant data shows Leases for NBP at $2.8 million in Q4 2025, $3.0 million in Q3 2025, and $3.2 million in Q2 2025.